Lonestar Medicines
Boston, US · Founded 2025 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
WD
William Daley BonificioExecutive Officer, Promoter
SB
Stephen Basil ThomasExecutive Officer, Director, Promoter
NM
Naveen Manu DaryaniExecutive Officer
AL
Andrew LevinDirector
GH
Gianna Hoffman-LucaDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$25MraisedFeb 2026 · 4 investors · BiotechnologyRule 506(b)
▶$25MraisedFeb 2026 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Naveen Manu DaryaniExecutive Officer
- Andrew LevinDirector
- William Daley BonificioExecutive Officer, Promoter
- Gianna Hoffman-LucaDirector
- Stephen Basil ThomasExecutive Officer, Director, Promoter
- Offering amount
- $45M
- Amount sold
- $25M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.